Overview

Zonisamide Augmentation of Varenicline Treatment for Smoking Cessation

Status:
Completed
Trial end date:
2014-05-01
Target enrollment:
Participant gender:
Summary
Randomized trial to evaluate whether zonisamide can enhance varenicline-induced smoking cessation.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
Johns Hopkins University
Collaborator:
National Institute on Drug Abuse (NIDA)
Treatments:
Nicotine
Varenicline
Zonisamide